Carly Golden
About Carly Golden
Carly Golden is a Senior Research Associate on the Preclinical Team at StrideBio, Inc., where she has worked since 2019. She holds a Master of Science from Brandeis University and has prior experience in various research roles, including positions at Icagen and Biogen.
Current Role at StrideBio
Carly Golden serves as a Senior Research Associate on the Preclinical Team at StrideBio, Inc. She has held this position since 2019, contributing to the company's research initiatives in Raleigh, North Carolina. Her role involves supporting preclinical studies and collaborating with team members to advance the development of gene therapies.
Previous Experience at Icagen
Before joining StrideBio, Carly worked as an Associate Scientist at Icagen from 2018 to 2019 for a duration of six months. During her time at Icagen in Raleigh, North Carolina, she gained experience in the biotechnology sector, focusing on research and development.
Educational Background
Carly Golden earned her Master of Science degree from Brandeis University, where she studied from 2016 to 2017. Prior to this, she completed her Bachelor's degree at Mansfield University of Pennsylvania from 2014 to 2016. Additionally, she has attended Northampton Community College and Harrisburg University of Science and Technology, further enriching her academic foundation.
Research Roles at Academic Institutions
Carly has held various research positions during her academic career. She worked as a Graduate Student Researcher at Brandeis University for eight months from 2016 to 2017. Additionally, she served as an Undergraduate Student Researcher at Mansfield University of Pennsylvania from 2015 to 2016. These roles provided her with practical research experience in biology.
Co-op Experience at Biogen
Carly gained valuable industry experience as a Cell Line Development and Gene Therapy Co-op at Biogen from 2017 to 2018. This position, located in Cambridge, Massachusetts, allowed her to apply her academic knowledge in a professional setting, focusing on gene therapy development.